Clinical Trial Update: Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. [Phase 2]

View source ↗

Summary

Phase 2 study of inhaled GeNOsyl for pulmonary arterial hypertension and pulmonary hypertension due to idiopathic pulmonary fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Pulmonary Arterial Hypertension

Drugs mentioned

• GENOSYL (Nitric Oxide)

Snippet

Sponsor: Geno LLC | Conditions: Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED